title: Methodological aspects of multicenter studies with quantitative PET.
abstract: Quantification of whole-body FDG PET studies is affected by many physiological and physical factors. Much of the variability in reported standardized uptake value (SUV) data seen in the literature results from the variability in methodology applied among these studies, i.e., due to the use of different scanners, acquisition and reconstruction settings, region of interest strategies, SUV normalization, and/or corrections methods. To date, the variability in applied methodology prohibits a proper comparison and exchange of quantitative FDG PET data. Consequently, the promising role of quantitative PET has been demonstrated in several monocentric studies, but these published results cannot be used directly as a guideline for clinical (multicenter) trials performed elsewhere. In this chapter, the main causes affecting whole-body FDG PET quantification and strategies to minimize its inter-institute variability are addressed.
authors.affiliation: Department of Nuclear Medicine & PET Research, VU University Medical Centre, Amsterdam, The Netherlands. r.boellaard@vumc.nl
authors.forename: Ronald
authors.initials: R
authors.lastname: Boellaard
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D015337:Multicenter Studies as Topic; D049268:Positron-Emission Tomography / Q000379:methods* / Q000592:standards*; D011786:Quality Control; D019275:Radiopharmaceuticals; D051598:Whole Body Imaging / Q000379:methods / Q000592:standards
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18